Kerget, B. Et Al. 2020. Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?. Turkish journal of medical sciences , vol.50, no.4 , 963-968.

Kerget, B., Afşin, D., Aksakal, A., Aksakal, A., Aşkin, S., & Araz, Ö., (2020). Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?. Turkish journal of medical sciences , vol.50, no.4, 963-968.

Kerget, Buğra Et Al. "Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?," Turkish journal of medical sciences , vol.50, no.4, 963-968, 2020

Kerget, Buğra Et Al. "Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?." Turkish journal of medical sciences , vol.50, no.4, pp.963-968, 2020

Kerget, B. Et Al. (2020) . "Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?." Turkish journal of medical sciences , vol.50, no.4, pp.963-968.

@article{article, author={Buğra KERGET Et Al. }, title={Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?}, journal={Turkish journal of medical sciences}, year=2020, pages={963-968} }